Immunomodulatory effect of β-carotene on T lymphocyte subsets in patients with resected colonic polyps and cancer

Nutrition and Cancer

Volumn 28, Issue 2, 1997, Pages 140-145

  Kazi, Nadeem ^a   Radvany, Ruta ^b   Oldham, Todd ^a   Keshavarzian, Ali ^a   Frommel, Thomas O ^a   Libertin, Claudia ^b   Mobarhan, Sohrab ^a,b  

^a Department of Medicine   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; RETINOIC ACID; RETINOL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; COLON CANCER; COLON POLYP; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

EID: 0030774721     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589709514566     Document Type: Article

References (47)

1. Fontham, ET: "Protective dietary factors and lung cancer." Int J Epidemiol 19, S32-S42, 1990.
2. Singh, VN, and Gaby, SK: "Premalignant lesions: role of antioxidant vitamins and β-carotene in risk reduction and prevention of malignant transformation." Am J Clin Nutr 53, 386S-390S, 1991.
3. Wald, NJ, Thompson, SG, Densem, JW, Boreham, J, and Bailey, A: "Serum β-carotene and subsequent risk of cancer: result from the BUPA study." Br J Cancer 57, 428-433, 1988.
4. Ziegler, RG: "A review of epidemiological evidence that carotenoids reduce the risk of cancer." J Nutr 119, 116-122, 1989.
5. Stahelin, HB, Rosel, F, Buess, E, and Brubacher, G: "Cancer, vitamins, and plasma lipids: prospective basal study." JNCI 73, 1463-1468, 1984.
6. Gey, F, and Brubacher, GB: "Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer." Am J Clin Nutr 45, 1368-1377, 1987.
7. Kneller, RW, Guo, W-D, Hsing, AW, Chen, J-S, Blot, WJ, et al.: "Risk factors for stomach cancer in sixty-five Chinese counties." Cancer Epidemiol Biomarkers Prev 1, 113-118, 1992.
8. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: "The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancer in male smokers." N Engl J Med 330, 1029-1035, 1994.
9. Greenberg, ER, Baron, JA, Tosteson, TD, Freeman, DH, Beck, GJ, et al.: "A clinical trial of antioxidant vitamins to prevent colorectal adenoma." N Engl J Med 331, 141-147, 1994.
10. Omenn, GS, Goodman, GE, Thornquist, MD, Balmes, J, Cullen, MR, et al.: "Risk factors for lung cancer and for intervention effect in CARET, the β-carotene and retinol efficacy trial." JNCI 88, 1550-1559, 1996.
11. Burton, GW, and Ingold, KV: "β-Carotene: an unusual type of lipid antioxidant." Science 224, 569-573, 1984.
12. Burton, GW: "Antioxidant actions of carotenoids." J Nutr 19, 109-111, 1989.
13. Bendich, A: "A role for carotenoids in immune function." Clin Nutr 7, 113-117, 1988.
14. Watson, RR, Jackson, JC, Leigh, S, Hicks, MJ, and Alberts, DS: "Cellular immune functions of adults treated with a long-term low dose of 13-cis retinoic acid." J Leukocyte Biol 116, 2254-2262, 1986.
15. Peto, R, Doll, R, Buckley, JD, and Sporn, MB: "Can dietary β-carotene materially reduce human cancer rates?" Nature 290, 201-208, 1981.
16. Krinsky, NI, and Deneke, S: "Interaction of oxygen and oxy-radicals with carotenoids." JNCI 69, 205-210, 1982.
17. Hennekens, CH, Mayrent, SL, and Willett, W: "Vitamin A, carotenoids, and retinoids." Cancer 58, 1837-1841, 1986.
18. Zhang, LX, Cooney, RV, and Bertram, JS: "Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/ 10T1/2 cells: relationship to their cancer chemoprevention action." Carcinogenesis 12, 2109-2114, 1991.
19. Stacewicz-Sapuntzakis, M, Bowen, PE, Kikendall, JW, and Burgess, M: "Simultaneous determination of serum retinol and various carotenoids: their distribution in middle-aged men and women." J Micronutr Anal 3, 27-45, 1987.
20. Tang, G, Shiau, A, Russell, RM, and Mobarhan, S: "Serum retinoic acid levels in patients with resected benign and malignant colonic neoplasias on β-carotene supplementation." Nutr Cancer 23, 291-298, 1995.
21. Becton-Dickinson: "Direct immunofluorescence staining of cell surfaces." In Becton-Dickinson Procedures Sourcebook. Sunnyvale, CA: Becton-Dickinson Immunocytometry Systems, 1989, sect 2.4.
22. Mobarhan, S, Shiau, A, Grande, A, Srinivas, K, Stacewicz-Sapuntzakis, M, et al.: "β-Carotene supplementation results in an increased serum and colonic mucosal concentration of β-carotene and a decrease in α-tocopherol concentration in patients with colonic neoplasia." Cancer Epidemiol Biomarkers Prev 3, 501-505, 1994.
23. Frommel, TO, Mobarhan, S, Doria, M, Halline, AG, Luk, GD, et al.: "Effect of β-carotene supplementation on indices of colonic cell proliferation." JNCI 87, 1781-1787, 1995.
24. Costantino, JP, Kuller, LH, Begg, L, Redmond, CK, and Bates, MW: "Serum level changes after administration of a pharmacologic dose of β-carotene." Am J Clin Nutr 48, 1277-1283, 1988.
25. Albanes, D, Virtamo, J, Rautalahti, M, Haukka, J, Palmgren, J, et al.: "Serum β-carotene before and after β-carotene supplementation." Eur J Clin Nutr 46, 15-24, 1992.
26. + cells in human blood." Immunol Lett 9, 221-224, 1985.
27. Watson, RR, Prabhala, RH, Plezia, PM, and Alberts, DS: "Effect of β-carotene on lymphocyte subpopulation in elderly humans: evidence for a dose-response relationship." Am J Clin Nutr 53, 90-94, 1991.
28. Ringer, TV, DeLoof, MJ, Winterrowd, GE, Francom, SF, Gaylor, SK, et al.: "β-Carotene's effects on serum lipoproteins and immunologic indices in humans." Am J Clin Nutr 53, 688-694, 1991.
29. Van Poppel, G, Spanhaak, S, and Ockhuizen, T: "Effect of β-carotene on immunological indexes in healthy male smokers." Am J Clin Nutr 57, 402-407, 1993.
30. Murata, T, Hiroshi, T, Morinobu, T, Manago, M, Takenaka, H, et al.: "Effect of long-term administration of β-carotene on lymphocyte subsets in humans." Am J Clin Nutr 60, 597-602, 1994.
31. Coodley, GO, Nelson, HD, Loveless, MO, and Folk, C: "β-Carotene in HIV infection." J Acquired Immune Deficiency Syndrome 6, 272-276, 1993.
32. Prabhala, RH, Braune, LM, Garewal, HS, and Watson, RR: "Influence of β-carotene on immune function." Ann NY Acad Sci 691, 262-263, 1993.
33. Stewart, TH, Hollinshead, AC, and Raman, S: "Tumour dormancy: initiation, maintenance and termination in animals and humans." Can J Surg 34, 321-325, 1991.
34. + T cells to suppress recognition of allogenic and syngeneic MHC class II molecules." J Leukocyte Biol 52, 661-669, 1992.
35. Waldmann, TA: "Multichain IL-2 receptor: a target for immunotherapy in lymphoma." JNCI 81, 914-923, 1989.
36. Waldmann, TA: "The structure, function, and expression of IL2 receptor on normal and malignant lymphocytes." Science 232, 727-732, 1986.
37. Robb, RJ, Munck, A, and Smith, KA: "T cell growth factor receptors: quantitation, specificity, and biological relevance." J Exp Med 154, 1455-1474, 1981.
38. Trinchieri, G, Matsumoto-Kobayashi, M, Clark, SC, Seehra, J, London, L, et al.: "Response of resting human peripheral blood natural killer cells to interleukin 2." J Exp Med 160, 1147-1159, 1984.
39. McGuire, KL, Yang, JA, and Rothenburg, EV: "Influence of activating stimulus on functional phenotype: interleukin-2 mRNA accumulation differently induced by ionophore and receptor ligands in subsets of murine T cells." Proc Natl Acad Sci USA 85, 6503-6507, 1988.
40. + natural killer cells." Eur J Immunol 18, 1827-1830, 1988.
41. Teodorczyk-Injeyan, JA, Sparkes, BG, Mills, GB, Peters, WJ, and Falk, RE, et al.: "Impairment of T-cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression." Clin Exp Immunol 65, 570-581, 1986.
42. Kay, NE, and Kaplan, ME: "Defective T-cell responsiveness in chronic lymphocytic leukemia: analysis of activation events." Blood 67, 578-581, 1986.
43. Merluzzi, VJ, Welk, K, Savage, DM, Last-Barney, K, Mertelsmann, R, et al.: "Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2." J Immunol 131, 806-809, 1983.
44. Lissoni, P, Barni, S, Rovelli, F, Rescaldani, R, Biondi, A, et al.: "Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patients." Tumori 76, 14-17, 1990.
45. Rosenberg, SA, Lotze, MT, Yang, JC, Aebersold, PM, Linehan, WM, et al.: "Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients." Ann Surg 210, 474-485, 1989.
46. Yasumura, S, Lin, WC, Weidmann, E, Hebda, P, and Whiteside, TL: "Expression of interleukin-2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin-2." Int J Cancer 59, 225-234, 1994.
47. Maiani, G, Pappalardo, G, Ferro-Luzzi, A, Raguzzini, A, Azzini, E, et al.: "Accumulation of β-carotene in normal colorectal mucosa and colonic neoplastic lesions in humans." Nutr Cancer 24, 23-31, 1995.